High Free Cash Flow Stocks
COR is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
CENCORA INC (COR) Stock Price & Overview
NYSE:COR • US03073E1055
Current stock price
324.8 USD
+7.14 (+2.25%)
At close:
324.8 USD
0 (0%)
After Hours:
The current stock price of COR is 324.8 USD. Today COR is up by 2.25%. In the past month the price decreased by -9.6%. In the past year, price increased by 16.67%.
COR Key Statistics
52-Week Range267.399 - 377.54
Current COR stock price positioned within its 52-week range.
1-Month Range308.48 - 362.27
Current COR stock price positioned within its 1-month range.
- Market Cap
- 63.183B
- P/E
- 19.88
- Fwd P/E
- 16.33
- EPS (TTM)
- 16.34
- Dividend Yield
- 0.75%
COR Stock Performance
Today
+2.25%
1 Week
+2.13%
1 Month
-9.60%
3 Months
-4.15%
Longer-term
6 Months +7.28%
1 Year +16.67%
2 Years +35.87%
3 Years N/A
5 Years N/A
10 Years N/A
COR Stock Chart
COR Stock Screens
COR currently appears in the following ChartMill screener lists.
COR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to COR. When comparing the yearly performance of all stocks, COR turns out to be only a medium performer in the overall market: it outperformed 50.7% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
COR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to COR. Both the profitability and the financial health of COR get a neutral evaluation. Nothing too spectacular is happening here.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
COR Earnings
On February 4, 2026 COR reported an EPS of 4.08 and a revenue of 85.93B. The company beat EPS expectations (0.03% surprise) and missed revenue expectations (-1.1% surprise).
Next Earnings DateMay 5, 2026
Last Earnings DateFeb 4, 2026
PeriodQ1 / 2026
EPS Reported$4.08
Revenue Reported85.932B
EPS Surprise 0.03%
Revenue Surprise -1.10%
COR Forecast & Estimates
22 analysts have analysed COR and the average price target is 407.11 USD. This implies a price increase of 25.34% is expected in the next year compared to the current price of 324.8.
For the next year, analysts expect an EPS growth of 11.29% and a revenue growth 7.93% for COR
Analysts
Analysts82.73
Price Target407.11 (25.34%)
EPS Next Y11.29%
Revenue Next Year7.93%
COR Groups
Sector & Classification
Sector
Health Care Sub-Industry
Health Care Distributors COR Financial Highlights
Over the last trailing twelve months COR reported a non-GAAP Earnings per Share(EPS) of 16.34. The EPS increased by 14.99% compared to the year before.
Income Statements
Revenue(TTM)325.78B
Net Income(TTM)1.63B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.5% | ||
| ROA | 2.07% | ||
| ROE | 85.16% | ||
| Debt/Equity | 3.97 |
Chartmill High Growth Momentum
EPS Q2Q%9.38%
Sales Q2Q%5.45%
EPS 1Y (TTM)14.99%
Revenue 1Y (TTM)7.45%
COR Ownership
Ownership
Inst Owners96.15%
Shares194.53M
Float186.27M
Ins Owners0.09%
Short Float %2.64%
Short Ratio3.57
COR Latest News, Press Relases and Analysis
16 days ago - By: Chartmill
COR Competitors/Peers
The largest stocks on the US markets in the "Health Care Distributors" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 19.78 | 108.315B | ||
| CAH | CARDINAL HEALTH INC | 18.31 | 50.37B | ||
| HSIC | HENRY SCHEIN INC | 13.62 | 8.481B | ||
| AHCO | ADAPTHEALTH CORP | 11.87 | 1.635B | ||
| ACH | ACCENDRA HEALTH INC | 4.77 | 201.037M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 9.108M |
Related stock screener links
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About COR
Company Profile
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Company Info
IPO: 1996-05-28
CENCORA INC
1 West First Avenue
Conshohocken PENNSYLVANIA 80202 US
CEO: Paul E. Szurek
Employees: 51000
Phone: 13026587581
CENCORA INC / COR FAQ
What does COR do?
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
What is the current price of COR stock?
The current stock price of COR is 324.8 USD. The price increased by 2.25% in the last trading session.
What is the dividend status of CENCORA INC?
CENCORA INC (COR) has a dividend yield of 0.75%. The yearly dividend amount is currently 2.25.
How is the ChartMill rating for CENCORA INC?
COR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What do analysts say about CENCORA INC (COR) stock?
22 analysts have analysed COR and the average price target is 407.11 USD. This implies a price increase of 25.34% is expected in the next year compared to the current price of 324.8.
How is the valuation of CENCORA INC (COR) based on its PE ratio?
The PE ratio for CENCORA INC (COR) is 19.88. This is based on the reported non-GAAP earnings per share of 16.34 and the current share price of 324.8 USD.
Can you provide the upcoming dividend date for CENCORA INC?
The next ex-dividend date for CENCORA INC (COR) is February 13, 2026.